The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Liposome Drug Delivery-Global Market Insights and Sales Trends 2025

Liposome Drug Delivery-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1825743

No of Pages : 107

Ask Your Query

Synopsis

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

The global Liposome Drug Delivery market size is expected to reach US$ 8760.1 million by 2029, growing at a CAGR of 12.8% from 2023 to 2029. The market is mainly driven by the significant applications of Liposome Drug Delivery in various end use industries. The expanding demands from the Fungal Infection Therapy, Cancer & Tumor Therapy and Others,, are propelling Liposome Drug Delivery market. Liposomal Doxorubicin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liposomal Amphoteracin B segment is estimated at % CAGR for the next seven-year period.

Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Liposome Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Liposome Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Liposome Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Liposome Drug Delivery sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Liposome Drug Delivery covered in this report include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc.

The global Liposome Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Gilead Sciences
  • Pacira
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Luye Pharma
  • Sigma-Tau
  • Ipsen (Onivyde)
  • CSPC
  • Teva Pharmaceutical
  • Novartis
  • Fudan-Zhangjiang

Global Liposome Drug Delivery market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Liposome Drug Delivery market, Segment by Type:

  • Liposomal Doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others

Global Liposome Drug Delivery market, by Application

  • Fungal Infection Therapy
  • Cancer & Tumor Therapy
  • Others

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Liposome Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Index

1 Liposome Drug Delivery Market Overview
1.1 Liposome Drug Delivery Product Overview
1.2 Liposome Drug Delivery Market Segment by Type
1.2.1 Liposomal Doxorubicin
1.2.2 Liposomal Amphoteracin B
1.2.3 Liposomal Paclitaxel
1.2.4 Others
1.3 Global Liposome Drug Delivery Market Size by Type
1.3.1 Global Liposome Drug Delivery Market Size Overview by Type (2018-2029)
1.3.2 Global Liposome Drug Delivery Historic Market Size Review by Type (2018-2023)
1.3.3 Global Liposome Drug Delivery Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Liposome Drug Delivery Sales Breakdown by Type (2018-2023)
1.4.2 Europe Liposome Drug Delivery Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Liposome Drug Delivery Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Liposome Drug Delivery Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Liposome Drug Delivery Sales Breakdown by Type (2018-2023)
2 Global Liposome Drug Delivery Market Competition by Company
2.1 Global Top Players by Liposome Drug Delivery Sales (2018-2023)
2.2 Global Top Players by Liposome Drug Delivery Revenue (2018-2023)
2.3 Global Top Players by Liposome Drug Delivery Price (2018-2023)
2.4 Global Top Manufacturers Liposome Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type
2.5 Liposome Drug Delivery Market Competitive Situation and Trends
2.5.1 Liposome Drug Delivery Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Liposome Drug Delivery Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposome Drug Delivery as of 2022)
2.7 Date of Key Manufacturers Enter into Liposome Drug Delivery Market
2.8 Key Manufacturers Liposome Drug Delivery Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Liposome Drug Delivery Status and Outlook by Region
3.1 Global Liposome Drug Delivery Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Liposome Drug Delivery Historic Market Size by Region
3.2.1 Global Liposome Drug Delivery Sales in Volume by Region (2018-2023)
3.2.2 Global Liposome Drug Delivery Sales in Value by Region (2018-2023)
3.2.3 Global Liposome Drug Delivery Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Liposome Drug Delivery Forecasted Market Size by Region
3.3.1 Global Liposome Drug Delivery Sales in Volume by Region (2024-2029)
3.3.2 Global Liposome Drug Delivery Sales in Value by Region (2024-2029)
3.3.3 Global Liposome Drug Delivery Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Liposome Drug Delivery by Application
4.1 Liposome Drug Delivery Market Segment by Application
4.1.1 Fungal Infection Therapy
4.1.2 Cancer & Tumor Therapy
4.1.3 Others
4.2 Global Liposome Drug Delivery Market Size by Application
4.2.1 Global Liposome Drug Delivery Market Size Overview by Application (2018-2029)
4.2.2 Global Liposome Drug Delivery Historic Market Size Review by Application (2018-2023)
4.2.3 Global Liposome Drug Delivery Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Liposome Drug Delivery Sales Breakdown by Application (2018-2023)
4.3.2 Europe Liposome Drug Delivery Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Liposome Drug Delivery Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Liposome Drug Delivery Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Liposome Drug Delivery Sales Breakdown by Application (2018-2023)
5 North America Liposome Drug Delivery by Country
5.1 North America Liposome Drug Delivery Historic Market Size by Country
5.1.1 North America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Liposome Drug Delivery Sales in Volume by Country (2018-2023)
5.1.3 North America Liposome Drug Delivery Sales in Value by Country (2018-2023)
5.2 North America Liposome Drug Delivery Forecasted Market Size by Country
5.2.1 North America Liposome Drug Delivery Sales in Volume by Country (2024-2029)
5.2.2 North America Liposome Drug Delivery Sales in Value by Country (2024-2029)
6 Europe Liposome Drug Delivery by Country
6.1 Europe Liposome Drug Delivery Historic Market Size by Country
6.1.1 Europe Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Liposome Drug Delivery Sales in Volume by Country (2018-2023)
6.1.3 Europe Liposome Drug Delivery Sales in Value by Country (2018-2023)
6.2 Europe Liposome Drug Delivery Forecasted Market Size by Country
6.2.1 Europe Liposome Drug Delivery Sales in Volume by Country (2024-2029)
6.2.2 Europe Liposome Drug Delivery Sales in Value by Country (2024-2029)
7 Asia-Pacific Liposome Drug Delivery by Region
7.1 Asia-Pacific Liposome Drug Delivery Historic Market Size by Region
7.1.1 Asia-Pacific Liposome Drug Delivery Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Liposome Drug Delivery Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Liposome Drug Delivery Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Liposome Drug Delivery Forecasted Market Size by Region
7.2.1 Asia-Pacific Liposome Drug Delivery Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Liposome Drug Delivery Sales in Value by Region (2024-2029)
8 Latin America Liposome Drug Delivery by Country
8.1 Latin America Liposome Drug Delivery Historic Market Size by Country
8.1.1 Latin America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Liposome Drug Delivery Sales in Volume by Country (2018-2023)
8.1.3 Latin America Liposome Drug Delivery Sales in Value by Country (2018-2023)
8.2 Latin America Liposome Drug Delivery Forecasted Market Size by Country
8.2.1 Latin America Liposome Drug Delivery Sales in Volume by Country (2024-2029)
8.2.2 Latin America Liposome Drug Delivery Sales in Value by Country (2024-2029)
9 Middle East and Africa Liposome Drug Delivery by Country
9.1 Middle East and Africa Liposome Drug Delivery Historic Market Size by Country
9.1.1 Middle East and Africa Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Liposome Drug Delivery Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Liposome Drug Delivery Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Liposome Drug Delivery Forecasted Market Size by Country
9.2.1 Middle East and Africa Liposome Drug Delivery Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Liposome Drug Delivery Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Gilead Sciences
10.1.1 Gilead Sciences Company Information
10.1.2 Gilead Sciences Introduction and Business Overview
10.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Gilead Sciences Liposome Drug Delivery Products Offered
10.1.5 Gilead Sciences Recent Development
10.2 Pacira
10.2.1 Pacira Company Information
10.2.2 Pacira Introduction and Business Overview
10.2.3 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pacira Liposome Drug Delivery Products Offered
10.2.5 Pacira Recent Development
10.3 Sun Pharmaceutical
10.3.1 Sun Pharmaceutical Company Information
10.3.2 Sun Pharmaceutical Introduction and Business Overview
10.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sun Pharmaceutical Liposome Drug Delivery Products Offered
10.3.5 Sun Pharmaceutical Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Johnson & Johnson Liposome Drug Delivery Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Luye Pharma
10.5.1 Luye Pharma Company Information
10.5.2 Luye Pharma Introduction and Business Overview
10.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Luye Pharma Liposome Drug Delivery Products Offered
10.5.5 Luye Pharma Recent Development
10.6 Sigma-Tau
10.6.1 Sigma-Tau Company Information
10.6.2 Sigma-Tau Introduction and Business Overview
10.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sigma-Tau Liposome Drug Delivery Products Offered
10.6.5 Sigma-Tau Recent Development
10.7 Ipsen (Onivyde)
10.7.1 Ipsen (Onivyde) Company Information
10.7.2 Ipsen (Onivyde) Introduction and Business Overview
10.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ipsen (Onivyde) Liposome Drug Delivery Products Offered
10.7.5 Ipsen (Onivyde) Recent Development
10.8 CSPC
10.8.1 CSPC Company Information
10.8.2 CSPC Introduction and Business Overview
10.8.3 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.8.4 CSPC Liposome Drug Delivery Products Offered
10.8.5 CSPC Recent Development
10.9 Teva Pharmaceutical
10.9.1 Teva Pharmaceutical Company Information
10.9.2 Teva Pharmaceutical Introduction and Business Overview
10.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Teva Pharmaceutical Liposome Drug Delivery Products Offered
10.9.5 Teva Pharmaceutical Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Introduction and Business Overview
10.10.3 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Novartis Liposome Drug Delivery Products Offered
10.10.5 Novartis Recent Development
10.11 Fudan-Zhangjiang
10.11.1 Fudan-Zhangjiang Company Information
10.11.2 Fudan-Zhangjiang Introduction and Business Overview
10.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Fudan-Zhangjiang Liposome Drug Delivery Products Offered
10.11.5 Fudan-Zhangjiang Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Liposome Drug Delivery Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Liposome Drug Delivery Industrial Chain Analysis
11.4 Liposome Drug Delivery Market Dynamics
11.4.1 Liposome Drug Delivery Industry Trends
11.4.2 Liposome Drug Delivery Market Drivers
11.4.3 Liposome Drug Delivery Market Challenges
11.4.4 Liposome Drug Delivery Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Liposome Drug Delivery Distributors
12.3 Liposome Drug Delivery Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock